11-121102653-T-C

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_005422.4(TECTA):​c.-1-12T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0049 in 1,610,968 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0034 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0050 ( 32 hom. )

Consequence

TECTA
NM_005422.4 intron

Scores

2
Splicing: ADA: 0.5342
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.14

Publications

1 publications found
Variant links:
Genes affected
TECTA (HGNC:11720): (tectorin alpha) The tectorial membrane is an extracellular matrix of the inner ear that contacts the stereocilia bundles of specialized sensory hair cells. Sound induces movement of these hair cells relative to the tectorial membrane, deflects the stereocilia, and leads to fluctuations in hair-cell membrane potential, transducing sound into electrical signals. Alpha-tectorin is one of the major noncollagenous components of the tectorial membrane. Mutations in the TECTA gene have been shown to be responsible for autosomal dominant nonsyndromic hearing impairment and a recessive form of sensorineural pre-lingual non-syndromic deafness. [provided by RefSeq, Jul 2008]
TBCEL-TECTA (HGNC:54857): (TBCEL-TECTA readthrough) Predicted to enable alpha-tubulin binding activity. Predicted to be involved in microtubule cytoskeleton organization; post-chaperonin tubulin folding pathway; and tubulin complex assembly. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.23).
BP6
Variant 11-121102653-T-C is Benign according to our data. Variant chr11-121102653-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 227093.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00344 (524/152316) while in subpopulation NFE AF = 0.00542 (369/68034). AF 95% confidence interval is 0.00497. There are 1 homozygotes in GnomAd4. There are 224 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 32 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TECTANM_005422.4 linkc.-1-12T>C intron_variant Intron 1 of 23 ENST00000392793.6 NP_005413.2 O75443
TBCEL-TECTANM_001378761.1 linkc.957-12T>C intron_variant Intron 7 of 29 NP_001365690.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TECTAENST00000392793.6 linkc.-1-12T>C intron_variant Intron 1 of 23 5 NM_005422.4 ENSP00000376543.1 O75443
TBCEL-TECTAENST00000645041.1 linkc.909-12T>C intron_variant Intron 6 of 9 ENSP00000496315.1 A0A2R8YFB7

Frequencies

GnomAD3 genomes
AF:
0.00344
AC:
524
AN:
152198
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000845
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00360
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00367
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00544
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00399
AC:
994
AN:
249138
AF XY:
0.00387
show subpopulations
Gnomad AFR exome
AF:
0.000823
Gnomad AMR exome
AF:
0.00481
Gnomad ASJ exome
AF:
0.00270
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00342
Gnomad NFE exome
AF:
0.00556
Gnomad OTH exome
AF:
0.0111
GnomAD4 exome
AF:
0.00505
AC:
7364
AN:
1458652
Hom.:
32
Cov.:
30
AF XY:
0.00494
AC XY:
3587
AN XY:
725920
show subpopulations
African (AFR)
AF:
0.000629
AC:
21
AN:
33398
American (AMR)
AF:
0.00508
AC:
227
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00314
AC:
82
AN:
26112
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39670
South Asian (SAS)
AF:
0.00107
AC:
92
AN:
86178
European-Finnish (FIN)
AF:
0.00355
AC:
189
AN:
53220
Middle Eastern (MID)
AF:
0.00643
AC:
37
AN:
5758
European-Non Finnish (NFE)
AF:
0.00581
AC:
6443
AN:
1109318
Other (OTH)
AF:
0.00453
AC:
273
AN:
60282
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
316
632
947
1263
1579
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
246
492
738
984
1230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00344
AC:
524
AN:
152316
Hom.:
1
Cov.:
32
AF XY:
0.00301
AC XY:
224
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.000842
AC:
35
AN:
41562
American (AMR)
AF:
0.00360
AC:
55
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4826
European-Finnish (FIN)
AF:
0.00367
AC:
39
AN:
10622
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00542
AC:
369
AN:
68034
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
25
49
74
98
123
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00513
Hom.:
1
Bravo
AF:
0.00342
Asia WGS
AF:
0.00202
AC:
7
AN:
3476

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Apr 30, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

-13T>C in Promoter of TECTA: This variant is not expected to have clinical signi ficance because it has been identified in 0.6% (40/7020) of European American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washingt -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nonsyndromic Hearing Loss, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jun 25, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hearing loss, autosomal recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.23
CADD
Benign
22
DANN
Benign
0.89
PhyloP100
2.1
PromoterAI
0.0031
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.53
dbscSNV1_RF
Benign
0.40
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145916279; hg19: chr11-120973362; API